News

The Longaevus team took part in BIO-Europe

The participation of the Longaevus Technologies team in the 9th annual BIO-Europe event held on November 6-8, 2023 in Munich, Germany.

Ivan Morgunov (founder of Longaevus Technologies), Sherif Idriss (CEO of Elastin Therapeutics (Longaevus’ spin-off)), Francesca Lugarini (CEO of SeneXell Project (Longaevus’ spin-off)) and Alexander Fedintsev (a specialist in extracellular matrix biology and advisor of Longaevus Biotech) at Bio-Europe 2023 in Munich, Germany.
Longaevus Technologies announced the allocation of Elastin Biosciences

Longaevus Technologies is proud to announce the release of Elastin Biosciences, a significant breakthrough in the field of elastin-related health.

Longaevus Technologies is proud to announce the release of Elastin Biosciences, a significant breakthrough in the field of elastin-related health.
Longaevus Technologies has received a grant from HEALS

HEALS has awarded a grant for a project to extend the life of mice and counteract numerous age-related cell changes.

Longaevus Technologies at the Longevity Nation conference

At the Longevity Nation conference, Alexey Moskalev presented the results of a Pilot Mice experiment during the session on “Enhancing Research, Development, and Education for Healthy Longevity.”

Prof. Alexey Moskalev (founder and chief-scientist of Longaevus Technologies), Bar-Ilan University, Israel.
Longaevus founder Alexey Moskalev speak at the ARDD Congress

Alexey Moskalev (Founder of Longaevus) will speak at the ARDD Congress with a report on a combination approach to extending the life of mice.

Alexey Moskalev (founder and chef-scientist of Longaevus Technologies) Copenhagen, Denmark, 2022.
Longaevus Technologies at ARDD 2022

The Longaevus team attended the ARDD Congress in 2022.

Ivan Morgunov (the founder of Longaevus Technologies), Alexey Moskalev (founder and chief scientist of Longaevus Technologies) and Olga Borysova (Longaevus entrepreneur in residence) at ARDD 2022 in Copenhagen, Denmark, 2022.